Dashboard
Manage Tickers

TARA


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

protara-therapeutics-announces-results-from-thrive-1-a-study-evaluating-the-prevalence-of-choline-deficiency-and-liver-injury-in-patients-dependent-on-parenteral-support-expects-to-dose-first-patient-in-pivotal-pk-trial-for-iv-choline-chloride-in-q1-2025
Protara Therapeutics Announces Results Fro...
09/09/2024 12:09:04

78% of patients dependent on parenteral support were choline deficient, with 63% of these patients demonstrating liver dysfunct...

protara-therapeutics-completes-first-cohort-of-phase-2-starborn-1-trial-for-tara-002-in-pediatric-lymphatic-malformations-enrollment-ongoing-in-additional-cohorts-with-initial-results-expected-in-1h-2025
Protara Therapeutics Completes First Cohor...
09/09/2024 12:08:13

oppenheimer-maintains-outperform-on-protara-therapeutics-lowers-price-target-to-25
Oppenheimer Maintains Outperform on Protar...
08/12/2024 13:43:10

Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and lowers the price targ...

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
08/08/2024 11:26:29

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

protara-therapeutics-q2-eps-045-beats-080-estimate
Protara Therapeutics Q2 EPS $(0.45) Beats ...
08/06/2024 12:13:02

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of ...

Core News & Articles
Watching Protara Therapeutics, Opthea Ltd....
05/09/2024 14:24:33

https://blog.tipranks.com/these-2-strong-buy-penny-stocks-could-surge-over-400-says-oppenheimer/

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
05/06/2024 10:42:05

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

protara-therapeutics-q1-eps-097-misses-095-estimate
Protara Therapeutics Q1 EPS $(0.97) Misses...
05/02/2024 12:06:22

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.97) per share which missed the analyst consensus estimate o...

alphabet-to-rally-around-14-here-are-10-top-analyst-forecasts-for-monday
Alphabet To Rally Around 14%? Here Are 10 ...
04/22/2024 12:32:56

oppenheimer-maintains-outperform-on-protara-therapeutics-raises-price-target-to-30
Oppenheimer Maintains Outperform on Protar...
04/22/2024 11:21:21

Oppenheimer analyst Leland Gershell maintains Protara Therapeutics (NASDAQ:TARA) with a Outperform and raises the price targ...

hc-wainwright--co-maintains-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Maintains Buy on Prota...
04/08/2024 11:15:31

HC Wainwright & Co. analyst Andrew Fein maintains Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price ...

protara-therapeutics-shares-interim-data-from-bladder-cancer-study-raises-45m-via-equity
Protara Therapeutics Shares Interim Data F...
04/05/2024 16:57:57

Explore TARA-002's data in NMIBC treatment. Discover findings from three trials, including response rates, adverse events, ...

protara-therapeutics-shares-are-trading-higher-after-the-company-announced-alignment-with-the-fda-on-a-registrational-path-forward-for-intravenous-choline-chloride-the-company-also-announced-an-oversubscribed-45-million-private-placement-financing
Protara Therapeutics shares are trading hi...
04/05/2024 12:10:57

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
04/05/2024 12:09:50

protara-therapeutics-announces-oversubscribed-45m-private-placement-financing
Protara Therapeutics Announces Oversubscri...
04/05/2024 12:05:12

Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of can...

protara-therapeutics-announces-alignment-with-fda-on-registrational-path-forward-for-iv-choline-chloride-in-patients-dependent-on-parenteral-nutrition
Protara Therapeutics Announces Alignment W...
04/05/2024 12:03:48

hc-wainwright--co-reiterates-buy-on-protara-therapeutics-maintains-23-price-target
HC Wainwright & Co. Reiterates Buy on Prot...
03/14/2024 11:14:52

HC Wainwright & Co. analyst Andrew Fein reiterates Protara Therapeutics (NASDAQ:TARA) with a Buy and maintains $23 price...

protara-therapeutics-q4-eps-090-beats-092-estimate
Protara Therapeutics Q4 EPS $(0.90) Beats ...
03/13/2024 12:06:19

Protara Therapeutics (NASDAQ:TARA) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate of ...

12-health-care-stocks-moving-in-mondays-after-market-session
12 Health Care Stocks Moving In Monday's A...
03/04/2024 21:32:25

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
12/11/2023 13:06:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION